FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study

Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida

PR Newswire

ORANGE COUNTY, Calif., April 12, 2019 /PRNewswire/ — Novel physiologic results on world elite freedivers’ using the non-invasive MediPines Gas Exchange Monitor (https://bit.ly/2YVAG1M) were presented at the Experimental Biology 2019 conference. Dr. Philip Ainslie, Co-Director of the Centre for Heart, Lung and Vascular Health at the University of British Columbia, with his research team, conducted the study in Split, Croatia.


The recently FDA 510(k) cleared, MediPines Gas Exchange Monitor is a breakthrough, portable respiratory monitoring device invented to provide real-time, clinically actionable data. This ground-breaking technology is transforming the approach to measuring pulmonary gas exchange in a wide variety of clinical settings, relevant for the 33 million patients in the US (350 million globally), who suffer from respiratory disease.

The physiological demands placed on these world-class athletes are tremendous. “The transient stress on their lungs is similar to what is observed in patients who suffer from cardiac and respiratory disease.” It has been challenging, in the past, to assess the consequences of deep dives on pulmonary gas exchange, especially during true field-based conditions. “Measuring oxygen deficit has allowed us to establish the impact of ‘lung squeeze’ on gas exchange inefficiency in elite freedivers,” stated Dr. Philip Ainslie.

Oxygen deficit was developed for detecting gas exchange inefficiency using a simple, non-invasive method.  “Understanding gas exchange inefficiency in respiratory patients is fundamental to improving patient outcomes,” according to Dr. John B. West, the world-renowned physiologist who pioneered the concept.

Freedivers place themselves in extreme conditions, which push the outer limits of human lung physiology and can lead to high oxygen deficit. The device provided rapid feedback to the research team tasked with assessing the freedivers’ gas exchange status. “We hope that our device will continue to aid clinicians by providing patients’ respiratory status rapidly and conveniently in situations where direct gas exchange measurement is either difficult or impossible; the device also has clear application to field-based conditions,” said Steve Lee, CEO of MediPines. 

About MediPines:

MediPines Corporation, based in Orange County, California, is a pioneering medical device company established to advance respiratory medicine. For more information, visit https://medipines.com/.

For more information about University of British Columbia’s Centre for Heart, Lung and Vascular Health, visit https://chlvh.ok.ubc.ca/.


View original content to download multimedia:http://www.prnewswire.com/news-releases/fda-cleared-medipines-gas-exchange-monitor-measures-freedivers-lung-efficiency-in-ground-breaking-study-300831089.html

SOURCE MediPines

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

30 Jan 2019 Medical

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the MediPines Gas Exchange Monitor. The MediPines Gas Exchange Monitor provides clinicians with real-time pulmonary parameters and insights to support rapid triage and treatment decisions for respiratory conditions.

The MediPines Gas Exchange Monitor is the first technology of its kind to integrate a comprehensive set of respiratory parameters and innovative indices analyzed from a patient’s normal breathing samples in a simple, easy to administer breathing test in only a few minutes.

SOURCE: https://www.prnewswire.com/news-releases/medipines-announces-fda-clearance-of-breakthrough-respiratory-device-the-medipines-gas-exchange-monitor-300785572.html

Medipines - Clinical Results

Positive Clinical Results Presented at American Thoracic Society (ATS) Conference in San Diego, California.

20 May 2018 Health Care

A group of physicians and researchers presented initial findings at recently held ATS event in San Diego, California where they presented clinical study results, clinical implications and ongoing research areas. Additional opportunities were debated with other medical researchers and broader medical community.

Positive Clinical Results Presented

American Thoracic Society (ATS) Background

American Thoracic Society (ATS) is a nonprofit organization focused on improving care for pulmonary diseases, critical illnesses and sleep-related breathing disorders. It was established in 1905. It is the largest gathering of physicians, researches and clinicians in the respiratory fields, and recent gathering had about 15,000 attendees from around the world in San Diego. For more on ATS, please visit www.thoracic.org

Clinical Trial Results Published in CHEST - Medipines

Clinical Trial Results Published in CHEST Demonstrate Feasibility for Non-Invasive Gas Exchange Concept.

13 Feb 2018 Health Care

Non-invasive way to measure the degree of impaired gas exchange has been proposed and published with supporting study results.CHEST is a peer-reviewed medical journal covering chest diseases and related issues including pulmonology, cardiology, breathing, airway diseases and emergency medicine. The journal was established in 1935. For more on CHEST, https://journal.chestnet.org/

Clinical Trial Results Published